Evidence map›Paper›PMID 29494595›Full record

ArticlePloS one2018

Ratio of low molecular weight serum adiponectin to the total adiponectin value is associated with type 2 diabetes through its relation to increasing insulin resistance.

Minoru Iwata, Kazuo Hara, Yutaka Kamura, Hisae Honoki, Shiho Fujisaka, Manabu Ishiki, Isao Usui, Kunimasa Yagi, Yasuo Fukushima, Atsuko Takano and 7 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 1 country.

Minoru IwataFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Toyama, Japan.ORCID 0000-0003-2161-1313
Kazuo HaraDivision of Endocrinology and Metabolism, Department of Comprehensive Medicine, Saitama Medical Center, Jichi Medical University, Omiya-ku, Saitama, Japan.
Yutaka KamuraFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Toyama, Japan.
Hisae HonokiFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Toyama, Japan.
Shiho FujisakaFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Toyama, Japan.
Manabu IshikiFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Toyama, Japan.
Isao UsuiFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Toyama, Japan.
Kunimasa YagiFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Toyama, Japan.
Yasuo FukushimaDepartment of Internal Medicine, Asahi General Hospital, Asahi-machi, Toyama, Japan.
Atsuko TakanoDivision of Endocrinology and Metabolism, Department of Internal Medicine, Saiseikai Takaoka Hospital, Takaoka, Toyama, Japan.
Hiromi KatoDivision of Endocrinology and Metabolism, Department of Internal Medicine, Japan Community Health care Organization Takaoka Fushiki Hospital, Takaoka, Toyama, Japan.
Shihou MurakamiDivision of Endocrinology and Metabolism, Department of Internal Medicine, Toyama Rosai Hospital, Uozu, Toyama, Japan.
Kiyohiro HiguchiDepartment of Internal Medicine, JA Niigata Kouseiren Itoigawa General Hospital, Itoigawa, Niigata, Japan.
Chikaaki KobashiDepartment of Internal Medicine, Kamiichi General Hospital, Kamiichi-machi, Toyama, Japan.
Kazuhito FukudaDepartment of Internal Medicine, Fukuda Clinic, Himi, Toyama, Japan.
Yukiko KoshimizuDepartment of Internal Medicine, Urata Clinic, Kanazawa, Ishikawa, Japan.
Kazuyuki TobeFirst Department of Internal Medicine, Faculty of Medicine, University of Toyama, Toyama, Toyama, Japan.
University of Toyama · JPAsahi General Hospital · JPFukuda Denshi (Japan) · JPJapan Community Healthcare Organization · JPJichi Medical University · JPKamiichi General Hospital · JPSaiseikai Takaoka Hospital · JPToyama Rosai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimAmong the three adiponectin isoforms, a lower ratio of high molecular weight (HMW) adiponectin to total adiponectin (TA) is well known to cause insulin resistance and type 2 diabetes (T2D). However, how the levels of other adiponectin isoforms, such as the middle molecular weight (MMW) and low molecular weight (LMW) isoforms, and their relative ratio to TA change in T2D subjects has not been determined. Therefore, we investigated the association of these adiponectin-related parameters with T2D.

methodsWe examined the associations between adiponectin-related parameters and diabetes in a group of 394 T2D subjects and 374 controls (1st group) randomly selected from among the participants in our previous study. The associations between these parameters and the HOMA-IR in a 2nd group, consisting of the subjects remaining in the 1st group after the exclusion of subjects receiving diabetic medication, were also examined.

resultIn the 1st group, after adjusting for confounding factor, the levels of all the adiponectin isoforms and the HMW/TA ratio were significantly lower among the diabetic subjects than among the controls (all P values < 0.01). On the contrary, the LMW/TA ratio was significantly higher among the diabetic subjects (P < 0.01) and was positively associated with T2D (odds ratio = 8.64, P < 0.01). In the 2nd group, the HMW/TA ratio was inversely associated with the HOMA-IR; however, the LMW/TA ratio was positively associated with the HOMA-IR (β for LMW/TA ratio = 0.89, SE = 0.24, P < 0.001), similar to the association with T2D. The MMW/TA ratio was not associated with T2D or the HOMA-IR.

conclusionThe current investigation demonstrated that, unlike the reduction in the levels of all the adiponectin isoforms and the HMW/TA ratio, an increased LMW/TA ratio was associated with T2D through its relation to insulin resistance.

Indexed as

Insulin ResistanceAdiponectinAgedCohort StudiesDiabetes Mellitus, Type 2FemaleHumansMaleMiddle AgedMolecular WeightAdiponectinADIPOQ protein, human

Identifiers

PMID29494595
PMCPMC5832218
OpenAlexW2791668549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.